Top Key Companies for Neuroimaging Market: Toshiba Medical Systems, Varian Medical Systems, Sanrad Medical Systems Pvt. Ltd, Siemens AG, General Electric Company, Hitachi Medical systems, Philips Healthcare, Esaote SpA.
Global Neuroimaging Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Neuroimaging Market Overview And Scope:
The Global Neuroimaging Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Neuroimaging utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Neuroimaging Market Segmentation
By Type, Neuroimaging market has been segmented into:
Functional Magnetic Resonance Imaging (fMRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Electroencephalography (EEG)
Magneto Encephalography (MEG)
Near Infrared Spectroscopy (NIRS)
By Application, Neuroimaging market has been segmented into:
Hospitals
Ambulatory Surgical Centers
Clinics
Diagnostic Centers
Regional Analysis of Neuroimaging Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Neuroimaging Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neuroimaging market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Neuroimaging market.
Top Key Companies Covered in Neuroimaging market are:
Toshiba Medical Systems
Varian Medical Systems
Sanrad Medical Systems Pvt. Ltd
Siemens AG
General Electric Company
Hitachi Medical systems
Philips Healthcare
Esaote SpA
Key Questions answered in the Neuroimaging Market Report:
1. What is the expected Neuroimaging Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Neuroimaging Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Neuroimaging Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Neuroimaging Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Neuroimaging companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Neuroimaging Markets?
7. How is the funding and investment landscape in the Neuroimaging Market?
8. Which are the leading consortiums and associations in the Neuroimaging Market, and what is their role in the market?
Research Methodology for Neuroimaging Market Report:
The report presents a detailed assessment of the Neuroimaging Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Neuroimaging Market by Type
5.1 Neuroimaging Market Overview Snapshot and Growth Engine
5.2 Neuroimaging Market Overview
5.3 Functional Magnetic Resonance Imaging (fMRI)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Functional Magnetic Resonance Imaging (fMRI): Geographic Segmentation
5.4 Computed Tomography (CT)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Computed Tomography (CT): Geographic Segmentation
5.5 Positron Emission Tomography (PET)
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Positron Emission Tomography (PET): Geographic Segmentation
5.6 Electroencephalography (EEG)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Electroencephalography (EEG): Geographic Segmentation
5.7 Magneto Encephalography (MEG)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Magneto Encephalography (MEG): Geographic Segmentation
5.8 Near Infrared Spectroscopy (NIRS)
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Near Infrared Spectroscopy (NIRS): Geographic Segmentation
Chapter 6: Neuroimaging Market by Application
6.1 Neuroimaging Market Overview Snapshot and Growth Engine
6.2 Neuroimaging Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Ambulatory Surgical Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Ambulatory Surgical Centers: Geographic Segmentation
6.5 Clinics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clinics: Geographic Segmentation
6.6 Diagnostic Centers
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Diagnostic Centers: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Neuroimaging Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Neuroimaging Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Neuroimaging Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 TOSHIBA MEDICAL SYSTEMS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 VARIAN MEDICAL SYSTEMS
7.4 SANRAD MEDICAL SYSTEMS PVT. LTD
7.5 SIEMENS AG
7.6 GENERAL ELECTRIC COMPANY
7.7 HITACHI MEDICAL SYSTEMS
7.8 PHILIPS HEALTHCARE
7.9 ESAOTE SPA
Chapter 8: Global Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Functional Magnetic Resonance Imaging (fMRI)
8.2.2 Computed Tomography (CT)
8.2.3 Positron Emission Tomography (PET)
8.2.4 Electroencephalography (EEG)
8.2.5 Magneto Encephalography (MEG)
8.2.6 Near Infrared Spectroscopy (NIRS)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Ambulatory Surgical Centers
8.3.3 Clinics
8.3.4 Diagnostic Centers
Chapter 9: North America Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Functional Magnetic Resonance Imaging (fMRI)
9.4.2 Computed Tomography (CT)
9.4.3 Positron Emission Tomography (PET)
9.4.4 Electroencephalography (EEG)
9.4.5 Magneto Encephalography (MEG)
9.4.6 Near Infrared Spectroscopy (NIRS)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Ambulatory Surgical Centers
9.5.3 Clinics
9.5.4 Diagnostic Centers
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Functional Magnetic Resonance Imaging (fMRI)
10.4.2 Computed Tomography (CT)
10.4.3 Positron Emission Tomography (PET)
10.4.4 Electroencephalography (EEG)
10.4.5 Magneto Encephalography (MEG)
10.4.6 Near Infrared Spectroscopy (NIRS)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Ambulatory Surgical Centers
10.5.3 Clinics
10.5.4 Diagnostic Centers
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Functional Magnetic Resonance Imaging (fMRI)
11.4.2 Computed Tomography (CT)
11.4.3 Positron Emission Tomography (PET)
11.4.4 Electroencephalography (EEG)
11.4.5 Magneto Encephalography (MEG)
11.4.6 Near Infrared Spectroscopy (NIRS)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Ambulatory Surgical Centers
11.5.3 Clinics
11.5.4 Diagnostic Centers
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Functional Magnetic Resonance Imaging (fMRI)
12.4.2 Computed Tomography (CT)
12.4.3 Positron Emission Tomography (PET)
12.4.4 Electroencephalography (EEG)
12.4.5 Magneto Encephalography (MEG)
12.4.6 Near Infrared Spectroscopy (NIRS)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Ambulatory Surgical Centers
12.5.3 Clinics
12.5.4 Diagnostic Centers
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Functional Magnetic Resonance Imaging (fMRI)
13.4.2 Computed Tomography (CT)
13.4.3 Positron Emission Tomography (PET)
13.4.4 Electroencephalography (EEG)
13.4.5 Magneto Encephalography (MEG)
13.4.6 Near Infrared Spectroscopy (NIRS)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Ambulatory Surgical Centers
13.5.3 Clinics
13.5.4 Diagnostic Centers
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Neuroimaging Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Functional Magnetic Resonance Imaging (fMRI)
14.4.2 Computed Tomography (CT)
14.4.3 Positron Emission Tomography (PET)
14.4.4 Electroencephalography (EEG)
14.4.5 Magneto Encephalography (MEG)
14.4.6 Near Infrared Spectroscopy (NIRS)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Ambulatory Surgical Centers
14.5.3 Clinics
14.5.4 Diagnostic Centers
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Neuroimaging Scope:
|
Report Data
|
Neuroimaging Market
|
|
Neuroimaging Market Size in 2025
|
USD XX million
|
|
Neuroimaging CAGR 2025 - 2032
|
XX%
|
|
Neuroimaging Base Year
|
2024
|
|
Neuroimaging Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Toshiba Medical Systems, Varian Medical Systems, Sanrad Medical Systems Pvt. Ltd, Siemens AG, General Electric Company, Hitachi Medical systems, Philips Healthcare, Esaote SpA.
|
|
Key Segments
|
By Type
Functional Magnetic Resonance Imaging (fMRI) Computed Tomography (CT) Positron Emission Tomography (PET) Electroencephalography (EEG) Magneto Encephalography (MEG) Near Infrared Spectroscopy (NIRS)
By Applications
Hospitals Ambulatory Surgical Centers Clinics Diagnostic Centers
|